Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
Shakeel McKenzie, Carol Taoushanis, Lindie Rossouw, Hylton Rodel, Sarah Rhead, Sureshnee Pillay, Faeezah Patel, Suzette Oelofse, Andrew Moultrie, Kgaogelo Molapo, Houriiyah Tegally, Mduduzi Masilela, Masebole Masenya, Mookho Malahleha, Matt Laubscher, Teresa Lambe, Aylin Jose, Shi-Hsia Hwa, Elizea Horne, Marisa Groenewald, Tulio de Oliveira, Alane Izu, Alex Sigal, Penny L Moore, Aliasgar Esmail, Andrew J Pollard, Sarah Gilbert, Tonya L Villafana, Elizabeth J Kelly, Nicholas M Durham, Constantinos K Wibmer, Samuel van Eck, Asha Thombrayil, Shaun L Barnabas, Jeanine du Plessis, As'ad E Bhorat, Jinal N Bhiman, Sutika Bhikha, Parvinder Aley, Khatija Ahmed, Gaurav Kwatra, Carmen Briner, Qasim E Bhorat, Keertan Dheda, Sherman D Padayachee, Lee Fairlie, Anthonet L Koen, Merryn Voysey, Clare L Cutland, Vicky Baillie, Shabir A Madhi
The New England journal of medicine 2021;384(20):1885-1898